TrialAmerican journal of clinical dermatology2019

Improvement in Patient-Reported Outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with Guselkumab in Moderate-to-Severe Plaque Psoriasis: Results from the Phase III VOYAGE 1 and VOYAGE 2 Studies.

April W Armstrong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.